<DOC>
	<DOCNO>NCT00419718</DOCNO>
	<brief_summary>The trial conduct Europe . This clinical pharmacology trial investigates effect exercise pharmacokinetics pharmacodynamics inhale insulin subject type 1 diabetes .</brief_summary>
	<brief_title>Effect Exercise Absorption Inhaled Human Insulin Subjects With Type 1 Diabetes</brief_title>
	<detailed_description />
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Diabetes Mellitus , Type 1</mesh_term>
	<mesh_term>Insulin , Globin Zinc</mesh_term>
	<mesh_term>Insulin</mesh_term>
	<criteria>Type 1 diabetes equal 12 month Baseline HbA1c less equal 11 % Body mass index ( BMI ) less equal 29 kg/m2 Normal lung volume Treatment intensify insulin therapy least 3 month Any present history pulmonary disease Any finding cardiopulmonary exercise test compromise safety moderate exercise Impaired hepatic renal function Cardiac problem Uncontrolled hypertension Current proliferative retinopathy maculopathy Treatment drug , may interfere insulin action , glucose metabolism recovery hypoglycaemia ( judged investigator ) Current smoke smoking within last 6 month Blood donation ( 500 mL ) within last nine week</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>January 2017</verification_date>
</DOC>